Drugs Made In America Acquisition Corp. Rights
DMAAR
$0.12-5.52%
Delayed · as of Oct 15, 2026, 2:01 PM ET
Mkt cap
$1.83M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (FY2025)
N/A
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
N/A
Drugs Made In America Acquisition Corp. Rights (DMAAR) right listed on US.
Use this DMAAR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full DMAAR income, balance, and cash tables.
Latest cached Drugs Made In America Acquisition Corp. Rights (DMAAR) net income for FY2025 was $5.9M. Statements: https://lician.com/financials/dmaar
Drugs Made In America Acquisition Corp. Rights (DMAAR) market capitalization is $1.8M on the latest cached snapshot.
Drugs Made In America Acquisition Corp. Rights (DMAAR) cached previous close $0.12; day range $0.10 – $0.12; volume 10,867. Session quote: https://lician.com/quote/dmaar
The latest cached DMAAR filing is 8-K · Sep 14, 2026. Filings: https://lician.com/sec/dmaar